Wilson Sonsini Goodrich & Rosati advised Ambient Fuels on the transaction. On May 17, 2023, Generate Capital, a leading sustainable infrastructure investment and operating company, announced...
Generate Capital’s Investment in Ambient Fuels
Oricell Therapeutics’ $45 Million Series B1 Financing
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
GE HealthCare’s Acquisition of Caption Health
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...
Project44’s $80 Million Funding Round
Wilson Sonsini advised project44 on the deal. project44, the leading supply chain visibility platform, announced that it raised an $80 million funding round led by sustainable...
AliveCor’s Series F Financing
Wilson Sonsini advised AliveCor on the deal. AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced its Series F Financing led by GE Healthcare....
InSilico Medicine’s $255 Million Series C Financing
Wilson Sonsini Goodrich & Rosati advised InSilico Medicine on the deal. Ashurst represented Mirae Asset Capital. Hong Kong-based InSilico Medicine, a global leader in end-to-end artificial...